MS14 Down-Regulates Lipocalin2 Expression in Spinal Cord Tissue in an Animal Model of Multiple Sclerosis in Female C57BL/6

Authors
Abbas Ebrahimi-Kalan
Jafar Soleimani Rad
Laya Kafami
Daryoush Mohammadnejad
Mehryar Habibi Roudkenar
Amir Afshin Khaki
Zeynab Aliyari Serej
Amaneh Mohammadi Roushandeh
10.6091/ibj.1375.2014
Abstract
Notice of the Full Retraction of the Above-Mentioned Article



Due to the redundant information presented in this paper and the paper published in the Iran Red Crescent Journal: "MS14, a Marine Herbal Medicine, an Immunosuppressive Drug in Experimental Autoimmune Encephalomyelitis. Iran Red Crescent Med J. 2014 July; 16(7): e16956, the editor/publisher primarily declared a notice of "partial retraction" (dated 26 August, 2020). But since the amount of redundant information was later found very significant (Figure-1 and the graph in Figure-2) and its omission would not leave a credible paper, IBJ was obliged to issue a notice of full retraction on 1 November 2020. The authors are not in agreement with this decision.





Notice of the Partial Retraction of the Above-Mentioned Article



The authors would like to retract Figure 1 from the paper entitled: “MS14 Down-regulates Lipocalin2 Expression in Spinal Cord Tissue in an Animal Model of Multiple Sclerosis in female C57BL/6”. The reason for this partial retraction is the duplicity of this Figure in the addressed paper and the paper entitled: “MS14, a Marine Herbal Medicine, an Immunosuppressive Drug in Experimental Autoimmune Encephalomyelitis” (Iran Red Crescent Med J, 2014 July; 16(7): e16956). The duplicity was inevitable, as the data was needed for the presentation of the rest of the data in the former paper, whereas the latter paper was not then published. However, considering both papers are published at this time, we would like to retract Figure 1 from the above-addressed paper.